Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
+11.8M
-
Total reported value, excl. options
-
$470M
-
Value change
-
+$156M
-
Put/Call ratio
-
0.37
-
Number of buys
-
58
-
Number of sells
-
-29
-
Price
-
$12.91
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2023
104 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2023.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
of 96M outstanding shares and own 37.95% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (4.57M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.27M shares), COMMODORE CAPITAL LP (2.37M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.34M shares), Cormorant Asset Management, LP (2.22M shares), Lynx1 Capital Management LP (2.18M shares), Bain Capital Life Sciences Investors, LLC (2M shares), VR Adviser, LLC (1.97M shares), VANGUARD GROUP INC (1.72M shares), and BlackRock Inc. (1.71M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.